Imperva stock: buy or sell?
January 9th, 2019
Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide.
Should I buy Imperva stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to choose your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Imperva stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Imperva stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't find any rating for IMPV stock for the last month.
Imperva stock analysis
Imperva ended on January at $55.74 and remained steady a neutral 0.02%.
Imperva shares remained constant 0.02% to $55.74 on January. Since SMA50d and SMA100d crossed up on November, IMPV price climbed $0.04 per share (0.07%). Since last October when IMPV stock price broke up the SMA100d line, it gained $12.68 (29.45%).
Shares of Imperva closed this week at $55.74 and stayed stable a tight 0.11%. For 4 weeks in a row, price soared and marked a profit of 0.49%.
Far behind is the all-time high Imperva hit by mid July 2018 but price is just -3.31% below that top. Since SMA10d and SMA20w crossed up late October 2018, IMPV price climbed $0.41 per share (0.74%). Since early October 2018 when IMPV stock price broke up the SMA20w line, it gained $11.86 (27.03%).
Imperva stock price history
Imperva IPO was on January 4th, 2018 at $42.35 per share1. Since then, IMPV stock surged a 31.60%, with an average of 31.60% per year. If you had invested right after IMPV's IPO a $1,000 in Imperva stock in 2018, it would worth $316.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Imperva stock historical price chart
IMPV stock reached all-time highs with a price of $57.65.
Imperva stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' IMPV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price prediction for Imperva stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on October, Imperva remained constant a neutral 0.70%. As soon as we get its actual EPS from the earnings report, we will extend this review. Imperva will present its financial report on February. Analysts expect an Earnings per Share (EPS) ratio of $0.14.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2017, Imperva annual revenues climbed an extraordinary 21.65% to $321.72 million USD from $264.46 marked in 2016. In the same way, its earnings margin (compared to sales) boosted to 7.11%, that is $22.87 million. Imperva presents anual results in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Imperva TTM sales up to September 2018 were $351.76 and income $-28.14 M USD. If we compare this TTM figures with the last reported annuality, we can review Imperva business evolution since December 2017: Annual turnover up to September, compared to lastest yearly report, escalated a cool 9.34%. Regarding profit margin, Imperva plunged -15.11% to 7.11%
|2013||$138 M||-||$-25.18 M-18.3%||-|
|2014||$164 M||19.05%||$-58.96 M-36.0%||134.17%|
|2015||$234 M||42.86%||$-48.88 M-20.9%||-17.10%|
|2016||$264 M||12.87%||$-70.28 M-26.6%||43.77%|
|2017||$322 M||21.65%||$23 M7.1%||-132.54%|
|TTM||$352 M||9.34%||$-28.14 M-8.0%||-223.03%|
Quarterly financial resultsImperva posted $91.63 M in sales for 2018-Q3, a 8.06% improvement compared to previous quarter. Reported quarter income marked $1.06 million with a profit margin of 1.15%. Profit margin rocketed a 28.35% compared to previous quarter when profit margin was -27.19%. When comparing revenues to same quarter last year, Imperva sales marked a great gain and soared a 9.23%. Looking back to recent quarterly results, Imperva posted 2 positive quarters in a row.
|2016-Q4||$78 M||-||$-9.82 M-12.5%||-|
|2017-Q1||$72 M||-7.77%||$23.08 M31.9%||-335.03%|
|2017-Q2||$74 M||2.95%||$-3.49 M-4.7%||-115.12%|
|2017-Q3||$84 M||12.69%||$-0.37 M-0.4%||-89.40%|
|2017-Q4||$91 M||8.57%||$3.65 M4.0%||-1,085.41%|
|2018-Q1||$84 M||-7.51%||$-9.78 M-11.6%||-368.27%|
|2018-Q2||$85 M||0.66%||$-23.06 M-27.2%||135.75%|
|2018-Q3||$92 M||8.06%||$1.06 M1.2%||-104.59%|
Imperva ownershipWhen you are planning to buy shares of a company, it's always worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Imperva, of all outstanding shares are owned by its staff.
The following table compares ownership indicators for other stocks related to Imperva:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Wednesday, January 9th, 2019|
|Day range||$55.71 - $55.75|
|Average true range||$0.10|
|50d mov avg||$55.65|
|100d mov avg||$51.94|
|200d mov avg||$50.21|
Imperva performanceTo better understand Imperva performance you must becnhmark its gains with other related stocks in same sector or industry. We chose as the bechmarking frame for Imperva stock.